v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows used in operating activities:    
Net income (loss) $ 55,208 $ (70,331)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 15,529 2,750
Stock-based compensation 41,250 14,232
Amortization of debt issuance cost 0 1,524
Loss on disposal of property and equipment 42 0
Non-cash lease amortization 1,388 1,445
Foreign currency gain/loss from remeasurement (871) (70)
Change in fair value of contingent acquisition liabilities (144,741) 3,080
Change in fair value of derivative (2,179) 0
Loss on early extinguishment of debt 0 15,587
Deferred income taxes 0 (368)
Other, net 1,997 (891)
Changes in operating assets and liabilities:    
Accounts receivable, net 2,383 211
Other current assets (2,696) (1,426)
Contract assets (6,314) (2,267)
Other non-current assets (1,846) (842)
Accounts payable 4,567 1,941
Accrued liabilities (6,210) (625)
Other current liabilities (2,481) 0
Operating lease liabilities (1,359) (1,720)
Deferred revenue (891) (2,523)
Other non-current liabilities 3,542 (147)
Net cash used in operating activities (43,682) (40,440)
Cash flows used in investing activities:    
Purchases of property and equipment (354) (335)
Payment related to acquisition, net of cash acquired 0 (4,453)
Net cash used in investing activities (354) (4,788)
Cash flows provided by financing activities:    
Proceeds from sales of Class A common stock under the Sales Agreement, Equity Distribution Agreement, and Second Equity Distribution Agreement 75,565 237,639
Proceeds from exercise of stock options and employee stock purchase plan 2,766 10,628
Proceeds from warrants exercised 13 0
Payment of financing costs associated with the Sales Agreement, Equity Distribution Agreement, and Second Equity Distribution Agreement (1,511) (5,639)
Payment to settle contingent holdback liabilities from SYNQ3 acquisition (198) 0
Payments on notes payable 0 (105,540)
Payments on finance leases (29) (58)
Net cash provided by financing activities 76,606 137,030
Effects of exchange rate changes on cash (210) 130
Net change in cash, cash equivalents, and restricted cash equivalents 32,360 91,932
Cash, cash equivalents, and restricted cash equivalents, beginning of period 198,916 109,035
Cash, cash equivalents, and restricted cash equivalents, end of period 231,276 200,967
Reconciliation to amounts on the condensed consolidated balance sheets:    
Cash and cash equivalents 230,340 200,156
Non-current portion of restricted cash equivalents 936 811
Total cash, cash equivalents, and restricted cash equivalents shown in the condensed consolidated statements of cash flows 231,276 200,967
Supplemental disclosures of cash flow information:    
Cash paid for interest 2 3,541
Cash paid for income taxes 1,905 1,274
Noncash or Part Noncash Acquisitions [Line Items]    
Conversion of Series A Preferred Stock to Class A common stock 0 14,187
Issuance of Class A Common Stock to settle contingent holdback consideration of SYNQ3 acquisition 3,922 0
Deferred offering costs reclassified to additional paid-in capital 79 147
Unpaid financing costs in connection with the Equity Distribution Agreement 0 522
Property and equipment acquired under accrued liabilities 0 92
Synq3, Inc    
Noncash or Part Noncash Acquisitions [Line Items]    
Fair value of Class A common stock and deferred equity consideration issued to acquire SYNQ3 0 9,687
Synq3, Inc | Contingent earnout consideration    
Noncash or Part Noncash Acquisitions [Line Items]    
Fair value of earnout and holdback consideration to acquire SYNQ3 0 1,676
Synq3, Inc | Contingent holdback consideration    
Noncash or Part Noncash Acquisitions [Line Items]    
Fair value of earnout and holdback consideration to acquire SYNQ3 0 427
Other Acquisition    
Noncash or Part Noncash Acquisitions [Line Items]    
Fair value of deferred cash consideration under other acquisition $ 0 $ 195